Search

Descubra cómo MSK ayuda a las personas que se enfrentan al cáncer en todo lo que necesitan, y comprende la importancia de hablar con los pacientes en el idioma que les brinda tranquilidad.

A team at MSK uncovered how TRX518, a new immunotherapy drug in early development, works in the body.

Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of its new Teen and Young Adult (TYA) Program, TYA  @  MSK, which will offer special services to MSK’s TYA population. In tandem, MSK officially opened The Lounge, a space designed especially for this unique age group that was made possible by a $1 million donation from Teen Cancer America. The nonprofit organization, co-founded by Roger Daltrey and Pete Townshend of The Who, partners with hospitals throughout the United States to develop specialized facilities for teens and young adults with cancer.

Patients with advanced kidney cancer can now take advantage of a new treatment option that has far fewer troubling side effects – this, according to a large, international trial led by Memorial Sloan Kettering Cancer Center investigators.

Vaccinating children against the human papillomavirus can protect them from developing many types of cancer. Here’s what you need to know.

Peter Scardino, MD, has been named the new Chairman of the Department of Surgery at Memorial Sloan Kettering Cancer Center.

Learn how nurses at MSK also engage in cancer research projects designed to help improve patients’ treatment, symptoms, or experience.

Biologists at Memorial Sloan Kettering Cancer Center have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor.